PMID: 16613582Apr 15, 2006Paper

Geminin as a molecular target for the development of new anticancer drugs

Mini Reviews in Medicinal Chemistry
Kenichi Yoshida

Abstract

The unique biological properties of Geminin, particularly as an inhibitor of DNA replication initiation, have been recognized, and this has prompted a number of investigations into this molecule to explore its potential therapeutic as well as diagnostic usefulness. This review summarizes the possibility of Geminin serving as a new molecular target in the development of new anticancer drugs.

Related Concepts

Related Feeds